Compare PLG & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLG | MASS |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.4M | 228.8M |
| IPO Year | 2002 | 2020 |
| Metric | PLG | MASS |
|---|---|---|
| Price | $1.82 | $7.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.0M | 247.5K |
| Earning Date | 04-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | N/A | $19.44 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | ★ N/A | $12.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $4.10 |
| 52 Week High | $4.04 | $9.34 |
| Indicator | PLG | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 63.71 |
| Support Level | $1.82 | $5.86 |
| Resistance Level | $1.89 | $7.42 |
| Average True Range (ATR) | 0.11 | 0.31 |
| MACD | 0.04 | 0.12 |
| Stochastic Oscillator | 74.29 | 86.62 |
Platinum Group Metals Ltd is a development-stage company, conducts work on mineral properties it has staked or acquired by way of option agreements in the Republic of South Africa. Key metals of economic interest on the company's mineral properties include platinum, palladium, rhodium, gold, copper, and nickel. The company operates in one segment, the development of the Waterberg Project in South Africa, and geographically in Canada and South Africa.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.